Leica Biosystems, a Danaher company, announced that the Company has completed its acquisition of privately held StatLab, a provider of pre-analytical consumables and equipment, from Linden Capital Partners and Audax Private Equity.
Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited, the UK operations of life sciences stability storage provider Sampled, located in Glasgow.
INEOS Inovyn has confirmed that it has agreed to acquire the remaining 50% shareholding in Runcorn MCP Limited following its entry into administration in 2025.
Corten Capital and Ampersand Capital Partners (“Ampersand”) have announced the completion of their acquisition of Beacon Intelligence from the Hanson Wade Group, backed by Graphite Capital.
Ampersand Capital Partners, a private equity firm with deep operational expertise scaling life sciences and healthcare companies, announced it has completed the sale of Tjoapack to Alcami Corporation.
Asahi Kasei, a diversified global company, announced the successful completion of its acquisition of Aicuris Anti-infective Cures (Aicuris), a German-based biopharmaceutical company.
Justin Wilson, partner and life sciences sector specialist at Withers & Rogers, highlights the importance of ensuring IP readiness ahead of an expected surge in M&A activity as the industry approaches the patent cliff.
ROIS, the CDMO arm of ROVI has announced closing the acquisition of an injectable drug product manufacturing and packaging site in Phoenix, Arizona (USA) from Bristol Myers Squibb.
Lupin has announced the completion of its acquisition of VISUfarma, a European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO).
